HEAL

Kexing Biopharmaceutical (688136.SH) has accomplished the impressive feat of being recognized on June 27 as one of “China’s Top 20 Biopharmaceutical Enterprises” (blood products, vaccines and insulin) for two consecutive years. This prestigious sub-list is part of the renowned “2022 China’s Top 100 Pharmaceutical Enterprises”. Kexing Biopharmaceutical’s inclusion can be attributed to its robust research…